CARLSBAD, Calif. – Thermo Fisher Scientific Launches 3,000 L and 5,000 L HyPerforma DynaDrive Single-Use Bioreactors (S.U.B.s) for Cell Culture Production

Further European expansion for G&L Scientific

Regulatory Affairs experts, G&L Scientific, have announced further expansion in Europe with new dedicated client services in Spain, Italy, Germany and France.

SB3000 ApS has been awarded a grant from the Danish Innovation Fund, to further refine its continuous manufacturing enabling technology μLOT® which will revolutionise the production of medicines

SB3000 is to receive grant funding from the Danish Innovation Fund to support its continuous manufacturing enabling technology for medicine production.

Northeast Georgia Health System Elevates Its Digital Consumer Experience with Self-Service Capabilities from Kyruus

VERICHEM LABORATORIES ANNOUNCES EXTENDED STABILITY CLAIMS FOR ITS AMMONIA/IRON CLINICAL REFERENCE STANDARD

VERICHEM LABORATORIES has announced that the open vial stability claim on its combined Ammonia/Iron Standard Kit has been extended to an exceptional twenty-four (24) months, making it ideal for numerous calibration verification events, or test system troubleshooting.

Standigm Secures $44.5 M in Pre-IPO Funding Round

Standigm, a leading AI-based drug discovery company, raised $44.5 M in a Pre-IPO round to go public on the Korea Exchange later in 2021.

Evolving Risks, Insecure Defaults, Watering Hole Threats: New Research from Accurics Uncovers Developing Sources of Cloud Risk

Formulationbio: A Leading Manufacturer of Excipients for Pharmaceutical Preparation

A good choice of excipient can lead to the formulation of stable dosage forms. To better meet the increasing demand for excipients, Formulationbio supplies a wide range of excipients for different research purposes, including binders, lubricants, diluents, disintegrants, emulsifiers, plasticizers, surfactants, sweeteners, fillers, stabilizers and so on.

Caroline O’Connor becomes new CCO of rare disease healthtech Raremark® amid rapid growth

Global rare disease specialist Raremark® appoints healthtech trailblazer Dale Jessop as new CTO

Ashfield Healthcare Communications rebrands as Ashfield Health, launches two new global agencies and appoints former McCann Health Americas head as Global President.

• Former 19-year McCann Health veteran, latterly President of the Americas, Amar Urhekar, joins as Global President of the >1,450 people-strong Ashfield Health network. • Ashfield Digital and Creative (UK), Cambridge BioMarketing (US) and Pegasus (UK) merge to form Mind+Matter, a new global, data-driven creative communications agency. • Ashfield Health’s 14 medical and scientific communications agencies come together to create Ashfield MedComms, a new 700 strong global powerhouse. • Ashfield Health agencies unified by common brand identity and shared new purpose to ‘make it matter’

Europital board forewarns that clinical deficits to slow biotech development in 2021

Ashfield Engage launches with an integrated offering to maximize engagement with patients, HCPs and payers

John Snow Labs Announces Inaugural Healthcare NLP Summit in Response to Industry Demand

John Snow Labs announces first-ever Healthcare NLP Summit, being held virtually from April 6-9.

SeqOnce Biosciences Announces RT-qPCR Assay to Detect SARS-CoV-2 N501Y Variant

SeqOnce Biosciences, Inc., announced today the launch of its new AzureSeq One-Step Universal RT-qPCR kit for the detection of the novel coronavirus SARS-CoV-2 N501Y variant. The AzureSeq One-Step Universal SARS-CoV-2 RT-qPCR N501Y kit uses a single-tube reaction targeting the N1 nucleocapsid gene, both alleles of S gene N501Y (A23063T), and includes RNaseP as a control. The assay uses common qPCR instruments with detection channels of FAM, HEX, Cy5, and ROX.

AARDEX Group and Pill Connect Ltd Partner to Empower Patient Adherence

CloudLIMS Announces Collaboration with Folio for Secure Issuance of COVID-19 Results to Patients

CloudLIMS’ COVID-19 LIMS solution has integrated with Folio's mobile app to enable receiving, storing, and sharing of COVID-19 test results securely and digitally.

NSTDA-BIOTEC selects Key Organics BIONET Fragment Library to identify new non-pyrimidine inhibitors of malaria parasite Plasmodium falciparum dihydrofolate reductase (PfDHFR).

In recent research at BIOTEC1 a three-step fragment-based screening of PfDHFR was undertaken employing Key Organics BIONET Premium library containing 1163 fragments. This library was chosen over other commercial ones as it is rule-of-three compliant and was curated from any PAINS and aggregating compounds. All fragments are also soluble at 200 mM in DMSO and display high diversity.

ComputaBio is Capable to provide Drug Design Services

ComputaBio, a US supplier of computational biology services, claims to be a capable helping hand in drug design for industrial and academic scientists worldwide to expedite their drug development projects.

VisualDx Launches Project IMPACT to Address Racism and Implicit Bias in Medicine